VIACORAM

This brand name is authorized in Canada, Ecuador, Estonia, Germany, Hong Kong SAR China, Ireland, Lithuania, Nigeria, Singapore, Spain.

Active ingredients

The drug VIACORAM contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII TFT5IM1KGB - PERINDOPRIL ARGININE
 

Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). The converting enzyme, or kinase, is an exopeptidase that allows conversion of angiotensin I into the vasoconstrictor angiotensin II as well as causing the degradation of the vasodilator bradykinin into an inactive heptapeptide. Inhibition of ACE results in a reduction of angiotensin II in the plasma, which leads to increased plasma renin activity (by inhibition of the negative feedback of renin release) and reduced secretion of aldosterone. Since ACE inactivates bradykinin, inhibition of ACE also results in an increased activity of circulating and local kallikrein-kinin systems (and thus also activation of the prostaglandin system).

 
Read more about Perindopril
2
UNII 864V2Q084H - AMLODIPINE BESYLATE
 

Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.

 
Read more about Amlodipine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09BB04 Perindopril and amlodipine C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BB ACE inhibitors and calcium channel blockers
Discover more medicines within C09BB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02451530, 02451549, 02451557
DE Bundesinstitut für Arzneimittel und Medizinprodukte 11194591, 11194622, 11194639, 11194674, 15378276, 15378282, 15378299, 15378307, 16260766, 16260772, 16260789, 16260803, 17627499, 17627507, 17627513, 17627536
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 2790-MEE-0617
EE Ravimiamet 1629143, 1629154, 1629165, 1629176, 1629187, 1629198, 1629200, 1629211, 1629222, 1629233, 1713080, 1713091, 1715284, 1715295, 1761926, 1761937, 1761948, 1761959
ES Centro de información online de medicamentos de la AEMPS 79868, 79871
HK Department of Health Drug Office 65793, 65794
LT Valstybinė vaistų kontrolės tarnyba 1071708, 1071709, 1071712, 1071713, 1076606, 1076607, 1076608, 1076609, 1076610, 1076611, 1079234, 1079235, 1080210, 1080211, 1084856, 1084857, 1084858, 1084859, 1092300
NG Registered Drug Product Database C4-0375, C4-0376
Switch country to Nigeria in order to find specific presentations of VIACORAM
SG Health Sciences Authority 15555P, 15556P, 15557P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.